1 year return (CAGR)
127.40%
Replimune Group Inc Exchange (NASDAQ, USD)
REPL
13.03
-0.08 (-0.61%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-12.89%
5 year return (CAGR)
-16.44%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.23B
Price/Sales
-
Ent value
1.19B
Price/Book
11.62
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
14.11%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.98 |
| Daily high | 13.06 |
| Daily low | 12.46 |
| Daily Volume | 2.15M |
| All-time high | 52.65 |
| 1y analyst estimate | 19.50 |
| Beta | 0.90 |
| EPS (TTM) | -3.07 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| REPL | S&P500 | |
| Current price drop from All-time high | -75.25% | -2.63% |
| Highest price drop | -96.77% | -56.47% |
| Date of highest drop | 13 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -56.25% | -10.68% |
| Avg time to new high | 60 days | 12 days |
| Max time to new high | 1453 days | 1805 days |
News
